Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Anticancer Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Celgene
AstraZeneca
Pfizer
Novartis
Roche
Teva Pharmaceuticals
Bayer
Bristol-Myers Squibb
By Type:
Hormonal Drugs
Targeted Drugs
Cytotoxic Drugs
By Application:
Chemotherapy
Immunotherapy
Others
Hormonal Therapy
Targeted Therapy
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Anticancer Drug Market Overview 2018-2029
-
1.1 China Anticancer Drug Industry Development Overview
-
1.2 China Anticancer Drug Industry Development History
-
1.3 China Anticancer Drug Industry Market Size (2018-2029)
-
1.4 China Anticancer Drug Market Analysis by Type from Production Side
-
1.4.1 China Anticancer Drug Production Volume, Production Value and Growth Rate of Hormonal Drugs (2018-2029)
-
1.4.2 China Anticancer Drug Production Volume, Production Value and Growth Rate of Targeted Drugs (2018-2029)
-
1.4.3 China Anticancer Drug Production Volume, Production Value and Growth Rate of Cytotoxic Drugs (2018-2029)
-
1.5 China Anticancer Drug Market Analysis by Application from Consumption End
-
1.5.1 China Anticancer Drug Sales Volume, Sales Value and Growth Rate of Chemotherapy (2018-2029)
-
1.5.2 China Anticancer Drug Sales Volume, Sales Value and Growth Rate of Immunotherapy (2018-2029)
-
1.5.3 China Anticancer Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.4 China Anticancer Drug Sales Volume, Sales Value and Growth Rate of Hormonal Therapy (2018-2029)
-
1.5.5 China Anticancer Drug Sales Volume, Sales Value and Growth Rate of Targeted Therapy (2018-2029)
-
1.6 China Anticancer Drug Market Analysis by Region
-
1.6.1 North China Anticancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Anticancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Anticancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Anticancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Anticancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Anticancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Anticancer Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Anticancer Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Anticancer Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Anticancer Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Anticancer Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Anticancer Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Anticancer Drug Industry Development
Chapter 3 Anticancer DrugIndustry Chain Analysis
-
3.1 Anticancer Drug Industry Chain
-
3.2 Anticancer Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Anticancer Drug Market
-
3.3 Anticancer Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Anticancer Drug Market
Chapter 4 China Anticancer Drug Market, by Type
-
4.1 China Anticancer Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Anticancer Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Anticancer Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Anticancer Drug Production Volume and Growth Rate of Hormonal Drugs
-
4.5.2 China Anticancer Drug Production Volume and Growth Rate of Targeted Drugs
-
4.5.3 China Anticancer Drug Production Volume and Growth Rate of Cytotoxic Drugs
Chapter 5 China Anticancer Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Anticancer Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Anticancer Drug Market Size and Growth Rate, by Application
-
5.5.1 China Anticancer Drug Market Size and Growth Rate of Chemotherapy
-
5.5.2 China Anticancer Drug Market Size and Growth Rate of Immunotherapy
-
5.5.3 China Anticancer Drug Market Size and Growth Rate of Others
-
5.5.4 China Anticancer Drug Market Size and Growth Rate of Hormonal Therapy
-
5.5.5 China Anticancer Drug Market Size and Growth Rate of Targeted Therapy
Chapter 6 China Anticancer Drug Market, by Region
-
6.1 China Anticancer Drug Production Volume and Production Value, by Region
-
6.2 China Anticancer Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Anticancer Drug Market Analysis
-
7.1 North China Anticancer Drug Market, by Type
-
7.2 North China Anticancer Drug Market, by Application
Chapter 8 Central China Anticancer Drug Market Analysis
-
8.1 Central China Anticancer Drug Market, by Type
-
8.2 Central China Anticancer Drug Market, by Application
Chapter 9 South China Anticancer Drug Market Analysis
-
9.1 South China Anticancer Drug Market, by Type
-
9.2 South China Anticancer Drug Market, by Application
Chapter 10 East China Anticancer Drug Market Analysis
-
10.1 East China Anticancer Drug Market, by Type
-
10.2 East China Anticancer Drug Market, by Application
Chapter 11 Northeast China Anticancer Drug Market Analysis
-
11.1 Northeast China Anticancer Drug Market, by Type
-
11.2 Northeast China Anticancer Drug Market, by Application
Chapter 12 Southwest China Anticancer Drug Market Analysis
-
12.1 Southwest China Anticancer Drug Market, by Type
-
12.2 Southwest China Anticancer Drug Market, by Application
Chapter 13 Northwest China Anticancer Drug Market Analysis
-
13.1 Northwest China Anticancer Drug Market, by Type
-
13.2 Northwest China Anticancer Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Celgene
-
14.1.1 Celgene Company Profile
-
14.1.2 Celgene Anticancer Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Profile
-
14.2.2 AstraZeneca Anticancer Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Pfizer
-
14.3.1 Pfizer Company Profile
-
14.3.2 Pfizer Anticancer Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Novartis
-
14.4.1 Novartis Company Profile
-
14.4.2 Novartis Anticancer Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Roche
-
14.5.1 Roche Company Profile
-
14.5.2 Roche Anticancer Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Teva Pharmaceuticals
-
14.6.1 Teva Pharmaceuticals Company Profile
-
14.6.2 Teva Pharmaceuticals Anticancer Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Bayer
-
14.7.1 Bayer Company Profile
-
14.7.2 Bayer Anticancer Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Bristol-Myers Squibb
-
14.8.1 Bristol-Myers Squibb Company Profile
-
14.8.2 Bristol-Myers Squibb Anticancer Drug Market Performance
-
14.8.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Anticancer Drug Industry Research Conclusions
-
15.2 Anticancer Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Anticancer Drug Industry Market Size (2018-2029)
-
Figure China Anticancer Drug Production Volume, Production Value and Growth Rate of Hormonal Drugs (2018-2029)
-
Figure China Anticancer Drug Production Volume, Production Value and Growth Rate of Targeted Drugs (2018-2029)
-
Figure China Anticancer Drug Production Volume, Production Value and Growth Rate of Cytotoxic Drugs (2018-2029)
-
Figure China Anticancer Drug Sales Volume, Sales Value and Growth Rate of Chemotherapy (2018-2029)
-
Figure China Anticancer Drug Sales Volume, Sales Value and Growth Rate of Immunotherapy (2018-2029)
-
Figure China Anticancer Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Anticancer Drug Sales Volume, Sales Value and Growth Rate of Hormonal Therapy (2018-2029)
-
Figure China Anticancer Drug Sales Volume, Sales Value and Growth Rate of Targeted Therapy (2018-2029)
-
Figure North China Anticancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Anticancer Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Anticancer Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Anticancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Anticancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Anticancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Anticancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Anticancer Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Anticancer Drug Market Share by Type in 2018
-
Figure China Anticancer Drug Market Share by Type in 2023
-
Figure China Anticancer Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Anticancer Drug Production Volume and Growth Rate of Hormonal Drugs (2018-2023)
-
Figure China Anticancer Drug Production Volume and Growth Rate of Targeted Drugs (2018-2023)
-
Figure China Anticancer Drug Production Volume and Growth Rate of Cytotoxic Drugs (2018-2023)
-
Figure China Anticancer Drug Market Share by Application in 2018
-
Figure China Anticancer Drug Market Share by Application in 2023
-
Figure China Anticancer Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Anticancer Drug Market Size and Growth Rate of Chemotherapy (2018-2023)
-
Figure China Anticancer Drug Market Size and Growth Rate of Immunotherapy (2018-2023)
-
Figure China Anticancer Drug Market Size and Growth Rate of Others (2018-2023)
-
Figure China Anticancer Drug Market Size and Growth Rate of Hormonal Therapy (2018-2023)
-
Figure China Anticancer Drug Market Size and Growth Rate of Targeted Therapy (2018-2023)
-
Table China Anticancer Drug Production Volume by Region (2018-2023)
-
Table China Anticancer Drug Production Volume Share by Region (2018-2023)
-
Figure China Anticancer Drug Production Volume Share by Region (2018-2023)
-
Table China Anticancer Drug Production Value by Region (2018-2023)
-
Table China Anticancer Drug Production Value Share by Region (2018-2023)
-
Figure China Anticancer Drug Production Value Share by Region (2018-2023)
-
Table China Anticancer Drug Sales Volume by Region (2018-2023)
-
Table China Anticancer Drug Sales Volume Share by Region (2018-2023)
-
Figure China Anticancer Drug Sales Volume Share by Region (2018-2023)
-
Table China Anticancer Drug Sales Value by Region (2018-2023)
-
Table China Anticancer Drug Sales Value Share by Region (2018-2023)
-
Figure China Anticancer Drug Sales Value Share by Region (2018-2023)
-
Table North China Anticancer Drug Production Volume by Type (2018-2023)
-
Table North China Anticancer Drug Production Volume Share by Type (2018-2023)
-
Figure North China Anticancer Drug Production Volume Share by Type (2018-2023)
-
Table North China Anticancer Drug Sales Volume by Application (2018-2023)
-
Table North China Anticancer Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Anticancer Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Anticancer Drug Production Volume by Type (2018-2023)
-
Table Central China Anticancer Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Anticancer Drug Production Volume Share by Type (2018-2023)
-
Table Central China Anticancer Drug Sales Volume by Application (2018-2023)
-
Table Central China Anticancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Anticancer Drug Sales Volume Share by Application (2018-2023)
-
Table South China Anticancer Drug Production Volume by Type (2018-2023)
-
Table South China Anticancer Drug Production Volume Share by Type (2018-2023)
-
Figure South China Anticancer Drug Production Volume Share by Type (2018-2023)
-
Table South China Anticancer Drug Sales Volume by Application (2018-2023)
-
Table South China Anticancer Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Anticancer Drug Sales Volume Share by Application (2018-2023)
-
Table East China Anticancer Drug Production Volume by Type (2018-2023)
-
Table East China Anticancer Drug Production Volume Share by Type (2018-2023)
-
Figure East China Anticancer Drug Production Volume Share by Type (2018-2023)
-
Table East China Anticancer Drug Sales Volume by Application (2018-2023)
-
Table East China Anticancer Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Anticancer Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Anticancer Drug Production Volume by Type (2018-2023)
-
Table Northeast China Anticancer Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Anticancer Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Anticancer Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Anticancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Anticancer Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Anticancer Drug Production Volume by Type (2018-2023)
-
Table Southwest China Anticancer Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Anticancer Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Anticancer Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Anticancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Anticancer Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Anticancer Drug Production Volume by Type (2018-2023)
-
Table Northwest China Anticancer Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Anticancer Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Anticancer Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Anticancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Anticancer Drug Sales Volume Share by Application (2018-2023)
-
Table Celgene Company Profile
-
Table Celgene Anticancer Drug Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Anticancer Drug Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Anticancer Drug Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Anticancer Drug Revenue, Price and Gross (2018-2023)
-
Table Roche Company Profile
-
Table Roche Anticancer Drug Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceuticals Company Profile
-
Table Teva Pharmaceuticals Anticancer Drug Revenue, Price and Gross (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Anticancer Drug Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Profile
-
Table Bristol-Myers Squibb Anticancer Drug Revenue, Price and Gross (2018-2023)
-
